Trial · NCT05173597
Real-world Evidence on Follitropin Delta Individual Dosing
NCT05173597, Recruiting, University of Luebeck
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Real-world Evidence on Follitropin Delta Individual Dosing. Trials, record NCT05173597. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05173597
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Real-world Evidence on Follitropin Delta Individual Dosing
- NCT number
- NCT05173597
- Status
- Recruiting
- Enrollment
- 850 participants, estimated
- Lead sponsor
- University of Luebeck
- Conditions
- Infertility, Sterility
- Interventions
- Follitropin delta
- First posted
- 2021-12-30
- Last updated
- 2025-03-30
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Ovarian response | 2021-2022 | Number of cumulus-oocyte-complexes of the individual dosing regimen of follitropin delta for controlled ovarian stimulation for in-vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) in a cohort of patients from a real-world setting with focus on high body weight. |
| Secondary | Overall treatment outcome | 2021-2022 | Incidence of live birth stratified for low, normal and high AMH and body weight |
| Secondary | Change in body weight | 2021-2022 | Determine change in body weight between 1st and 2nd cycle in subjects undergoing two cycles |
| Secondary | Incidence of dose changes | 2021-2022 | Incidence of dose changes between 1st and 2nd treatment cycle in subjects undergoing two cycles |
| Secondary | Intra-individual variation of ovarian response | 2021-2022 | Intra-individual variation of the number of cumulus-oocyte-complexes retrieved between 1st and 2nd treatment cycle in subjects undergoing two cycles, stratified for low, normal and high AMH and body weight and cycle regularity |
| Secondary | Measurement of correlation of variance of body weight and AMH | 2021-2022 | Correlation coefficient of variance of body weight and AMH with variance of ovarian response between 1st and 2nd cycle in subjects undergoing two cycles |
| Secondary | Comparison of intra-individual variance | 2021-2022 | Intra-individual variance in the number of cumulus-oocyte-complexes retrieved between first and second cycle in subgroups on the prospectively collected data and historical controls |
| Secondary | Safety of treatment | 2021-2022 | Incidence of adverse events related to treatment and assessed by CTCAE v4.0 of follitropin delta in a real-world setting |
| Secondary | Change in AMH | 2021-2022 | Difference in serum AMH values between 1st and 2nd cycle in subjects undergoing two cycles |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers18
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05173597
GET https://conductscience.org/api/trials/v1/NCT05173597/registered